Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study - Goss, G D; Arnold, A; Shepherd, F A (J Clin Oncol, 2010)
, et al.